Medical/Pharmaceuticals

MacuMira and Keeler announce global partnership to expand Dry AMD therapy

Partnership includes manufacturing and launch in Australia and New Zealand, with  additional markets to follow. WINDSOR, England and CALGARY, AB, Oct. 17, 2025 /PRNewswire/ -- Keeler

2025-10-17 04:35 1111

A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan

ROLLE, Switzerland and TOKYO, Oct. 16, 2025 /PRNewswire/ -- A.D.A.M. Innovations ,Japan's leading private genetic testing company, and SOPHiA GENETICS

2025-10-16 23:00 1810

SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology

BOSTON and ROLLE, Switzerland, Oct. 16, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in AI-driven precision medicine, today announced the launch of SOPHiA DDM™ Digital Twins, a breakthrough research technology that creates dynamic, virtual representations of individual patients t...

2025-10-16 16:01 1111

Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights

At ASHG, an early access customer from the London Health Sciences Center Research Institute demonstrated the power of the 5-base genome for accelerating resolution of rare disease cases  Proprietary 5-base chemistry and novel DRAGEN algorithms enable dual-omic inquiry,providing researchers with ...

2025-10-16 11:43 1046

ROSTI partners with IDC to bring innovative medical device design and manufacturing capabilities

SHANGHAI, Oct. 16, 2025 /PRNewswire/ -- A report from Ringiertrade. MedTec China 2025, which took place at the Shanghai World Expo Exhibition & Convention Center (SWEECC) fromSeptember 24-26, served as the ideal platform to promote the latest innovations in the production of medical devices. At t...

2025-10-16 11:30 1319

Gene Solutions Brings Insights on Advances in MRD and Multi-Omics Technologies to the Singapore Society of Oncology Annual Scientific Meeting 2025

SINGAPORE, Oct. 15, 2025 /PRNewswire/ -- What if cancer care could move from reactive to proactive? At the Singapore Society of Oncology Annual Scientific Meeting 2025 (SSO ASM 2025),Gene Solutions showcased how Molecular Residual Disease (MRD) and AI-powered multi-om...

2025-10-16 10:30 2133

DKSH Reinforces Patient-Centric Commitment with "Patient Purpose Day 2025", Spotlighting Women's Health Equity

DKSH Business Unit Healthcare continues bringing patient centricity to life with "Patient Purpose Day 2025". This global initiative, held for the third consecutive year across 12 markets across APAC andSwitzerland, reinforces DKSH's dedication to improving patient outcomes. This year, the program...

2025-10-16 10:00 870

PENTAX Medical Announces Sale of C2 CryoBalloon™ Product Line to Merit Medical Systems through Asset Purchase Agreement

Transaction supports PENTAX Medical's strategic focus on core flexible reusable endoscopy MONTVALE, N.J., Oct. 16, 2025 /PRNewswire/ -- PENTAX Medical, a division of HOYA Group and a global leader in flexible reusable endoscopy, today announced an asset purchase agreement with Merit Medical Syst...

2025-10-16 04:05 1464

TriNetX Becomes the Most Cited Real-World Data Source in Peer-Reviewed Research

With more than 2,000 citations and year-over-year growth nearing 80%, TriNetX outpaces competitors and fuels high-impact science published in top medical journals.  CAMBRIDGE, Mass., Oct. 15, 2025 /PRNewswire/ -- TriNetX, driven by its vision of a connected world where data and intelligence powe...

2025-10-15 20:34 1491

Tamarind Health Marks Next Phase as Asia's Leading Integrated Oncology Platform

SINGAPORE, Oct. 15, 2025 /PRNewswire/ -- Tamarind Health marks the next phase in its growth asAsia's leading integrated oncology-focused healthcare platform, following the completion of its acquisition of TalkMED inSeptember 2025. A doctor-led platform built on the principle of putting patients f...

2025-10-15 17:01 1144

Sinocare Showcases Its Comprehensive Diabetes Management Solutions at EASD

VIENNA, Oct. 15, 2025 /PRNewswire/ -- The 61st Annual Meeting of the European Association for the Study of Diabetes (EASD 2025) was successfully held in Vienna, Austria. During the conference, Sinocare hosted an international industry symposium and an exclusive networking dinner, fully demonstrati...

2025-10-15 14:34 1467

Safex Chemicals India Ltd. Receives Frost & Sullivan's 2025 Global Competitive Strategy Leadership Recognition for Excellence in Crop Protection Chemicals

Safex earns global recognition for its innovation-driven strategy, digital transformation, and customer-centric approach in the evolving crop protection chemicals industry. SAN ANTONIO, Oct. 15, 2025 /PRNewswire/ -- Frost & Sullivan

2025-10-15 14:00 1149

At the World Congress of Neurology, WHO Outlines a Global Roadmap to Make Brain Health a Universal Reality

SEOUL, South Korea and LONDON, Oct. 15, 2025 /PRNewswire/ -- Neurological conditions now affect more than 40% of the population—over 3 billion people, according to WHO's Global Status Report on Neurology, released at the World Congress of Neurology (WCN) inSeoul. The report reveals that neurolog...

2025-10-15 13:32 1025

Pictor's Proteomics Platform Offers Promising Advancement for Detecting Mycoplasma bovis in Cattle

New research highlights the Pictor PictVet™ Mycoplasma bovis IgG Multiplex ELISA's enhanced analytical performance through multiplexing and its potential to enhance global disease management.  CARLSBAD, Calif., Oct. 14, 2025 /PRNewswire/ -- Mycoplasma bovis is a devastating pathogen that threate...

2025-10-14 21:00 997

India's No:1 Ranked Institute IIT Madras partners with Hyundai Motor India to launch 'Hyundai Hope for Cancer' to revolutionize Paediatric Cancer Care

CHENNAI, India, Oct. 14, 2025 /PRNewswire/ -- Indian Institute of Technology Madras (IIT Madras),India's No:1 Ranked Educational Institution, is partnering with Hyundai Motor India Foundation (HMIF), the CSR arm of Hyundai Motor India Limited (HMIL), to launch 'Hyundai Hope for Cancer' - a pionee...

2025-10-14 20:30 1154

Infosys Chosen by NHSBSA to Deliver a New Workforce Management Solution for the NHS in England and Wales

Next-Generation solution supports the NHS 10-year Health Plan and the mission to create a workforce that is fit for the future LONDON and BENGALURU, India, Oct. 14, 2025 /PRNewswire/ -- Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation di...

2025-10-14 18:02 1122

Ascletis Completes Denifanstat (ASC40) Pre-NDA Consultation with China National Medical Products Administration

- Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne vulgaris compared with placebo in a Phase III randomized, double-blind, placebo-controlled, multicenter clinical trial. HONG KONG, Oct. 14, 2025...

2025-10-14 18:00 1473

Telix Reports US$206M Revenue, FY 2025 Guidance Upgraded

MELBOURNE, Australia and INDIANAPOLIS, Oct. 14, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today provides an update on its commercial and operational performance for the quarter ended30 September 2025 (Q3 2025). All figures are in USD unless stated otherwi...

2025-10-14 14:59 1574

Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) Presented Preclinical Data on GNTbm-TKI, a Novel Multi-tyrosine Kinase Inhibitor with Potent Immune Activation, at the 2025 ESMO Annual Meeting

TAIPEI, Oct. 14, 2025 /PRNewswire/ -- GNTbm (stock code: 7427, Taiwan) announced the preclinical data on GNTbm-TKI, a novel multi-receptor tyrosine kinase inhibitor for cancer immunotherapy. GNTbm-TKI will be presented as posters at the 2025European Society for Medical Oncology (ESMO) Annual Meet...

2025-10-14 14:26 1011

2025 ACR Abstract Released! Exciting Data from Telitacicept's Phase III Clinical Study in Sjögren's Syndrome in China

* In the results of China Phase III clinical trial announced at the 2025 ACR, Telitacicept demonstrated statistically significant and clinically meaningful improvements in ESSDAI [EULAR (European League Against Rheumatism) Sjögren's Syndrome Disease Activity Index] compared to placebo. * Teli...

2025-10-14 13:44 558
1 ... 23242526272829 ... 395

Week's Top Stories